What Researchers Did
Researchers compared the growth of 22 types of zygomycetes, a type of fungus, in normal air versus high-pressure oxygen environments, also testing their sensitivity to antifungal drugs.
What They Found
The study found that none of the 22 zygomycetes grew after 24 or 72 hours when incubated in a high-pressure oxygen atmosphere (2 or 3 ATA). In contrast, when kept in normal air conditions, fungal colonies were observed growing between 36 and 96 hours after being introduced. This suggests that high-pressure oxygen has a strong effect in stopping fungal growth, though its effectiveness depends on the exposure time.
What This Means for Canadian Patients
For Canadian patients suffering from severe fungal infections like zygomycosis, these findings suggest that hyperbaric oxygen therapy (HBOT) could potentially be a valuable addition to existing treatments. While this was an in vitro study, it indicates HBOT might help control fungal growth when used alongside antifungal medications and surgery. This could lead to better outcomes for patients battling these difficult-to-treat infections.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study was conducted in a laboratory setting using fungal cultures, meaning the results may not directly translate to how hyperbaric oxygen therapy would affect fungal infections within the human body.